Last reviewed · How we verify

NCT05396521

BFR Therapy Following DRF

Completed NA Last updated 9 October 2024
What this trial tests

NA trial testing Blood Flow Restriction in Distal Radius Fracture in 4 participants. Completed in 8 May 2023.

Timeline
26 May 2022
Primary endpoint
8 May 2023
8 May 2023

Quick facts

Lead sponsorCarilion Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment4
Start date26 May 2022
Primary completion8 May 2023
Estimated completion8 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Carilion Clinic

Who can join

Adults 50 to 75, any sex, with Distal Radius Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study's goal is to evaluate whether blood flow restriction supplemented therapy is a superior therapy compared to traditional standard of care while recovering from a surgery that repairs distal radius fractures. In order to measure this, subjects will be randomly assigned to either the traditional therapy group (with standard of care) or a blood flow restriction supplemented therapy group. All patients involved in this study will have had a distal radius fracture that is repaired with a technique called volar plating and the procedure will be done via an open technique. All subjects will be asked to fill out questionnaires that assess their pain and wrist functionality throughout the course of the study. These measurements will help understand whether the supplemented therapy is effective at reducing pain and improving functionality for patients who are recovering from this injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood Flow Restriction

Trials testing the same drug.

Other recruiting trials for Distal Radius Fracture

Currently open trials in the same condition.

Other Carilion Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing